Cargando…
N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
N(6)-methyladenosine (m(6)A) modification has been convincingly identified to be a critical regulator in human cancer. However, the contribution of m(6)A to NSCLC gefitinib resistance is still largely unknown. Here, we screened and identified that m(6)A methyltransferase KIAA1429 was highly expresse...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128911/ https://www.ncbi.nlm.nih.gov/pubmed/34001850 http://dx.doi.org/10.1038/s41420-021-00488-y |